Catinazzo Thomas, CFO of Relay Therapeutics ($RLAY), sold shares on the open market 12 times over the past year, totaling about $602 thousand. His most recent sale occurred on March 9, 2026. These sales rank him 6,062nd among 11,678 insiders in our database, where the average is $8.6 million across 6.4 transactions per insider. Thomas made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 17717 | $10.06 | 231,584.0000 | 173,322,385 | 7.11% | 0.01% |
| Jan. 27, 2026 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 13820 | $7.62 | 250,996.0000 | 173,322,385 | 5.22% | 0.01% |
| Jan. 28, 2026 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1695 | $8.45 | 249,301.0000 | 173,322,385 | 0.68% | 0.00% |
| Jan. 13, 2026 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 173,322,385 | 9999.99% | 0.23% |
| Oct. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 21664 | $7.29 | 313,631.0000 | 169,521,849 | 6.46% | 0.01% |
| July 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 18380 | $3.68 | 335,295.0000 | 169,521,849 | 5.20% | 0.01% |
| July 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1701 | $3.74 | 353,675.0000 | 169,521,849 | 0.48% | 0.00% |
| April 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 3558 | $3.23 | 368,319.0000 | 169,521,849 | 0.96% | 0.00% |
| April 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 12943 | $3.00 | 355,376.0000 | 169,521,849 | 3.51% | 0.01% |
| April 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 981 | $3.17 | 371,877.0000 | 169,521,849 | 0.26% | 0.00% |
| April 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1709 | $3.17 | 372,858.0000 | 169,521,849 | 0.46% | 0.00% |
| March 27, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 298 | $2.84 | 379,133.0000 | 169,521,849 | 0.08% | 0.00% |
| March 27, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 4566 | $2.84 | 374,567.0000 | 169,521,849 | 1.20% | 0.00% |
| Jan. 29, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 2109 | $4.55 | 400,222.0000 | 0 | 0.52% | 0.00% |
| Jan. 30, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 20791 | $4.42 | 379,431.0000 | 0 | 5.19% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 33753 | $4.63 | 265,473.0000 | 0 | 11.28% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 2283 | $4.63 | 263,190.0000 | 0 | 0.86% | 0.00% |
| Jan. 28, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Common Stock | 139141 | $0.00 | 402,331.0000 | 0 | 52.87% | 0.00% |
| Jan. 10, 2025 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Stock Option (Right to Buy) | 275000 | $0.00 | 275,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 4566 | $4.42 | 299,226.0000 | 0 | 1.50% | 0.00% |
| Dec. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 299 | $4.38 | 303,792.0000 | 0 | 0.10% | 0.00% |
| Oct. 28, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 5105 | $6.06 | 306,391.0000 | 0 | 1.64% | 0.00% |
| Oct. 28, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1697 | $6.06 | 311,496.0000 | 0 | 0.54% | 0.00% |
| Oct. 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 2300 | $5.95 | 304,091.0000 | 0 | 0.75% | 0.00% |
| Sept. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 6162 | $7.46 | 313,193.0000 | 0 | 1.93% | 0.00% |
| Sept. 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 295 | $7.51 | 319,355.0000 | 0 | 0.09% | 0.00% |
| July 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 9078 | $8.51 | 319,650.0000 | 0 | 2.76% | 0.00% |
| July 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1702 | $8.85 | 328,728.0000 | 0 | 0.52% | 0.00% |
| June 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 295 | $6.26 | 339,508.0000 | 0 | 0.09% | 0.00% |
| June 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 9078 | $6.24 | 330,430.0000 | 0 | 2.67% | 0.00% |
| April 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1695 | $6.38 | 339,803.0000 | 0 | 0.50% | 0.00% |
| March 27, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 348 | $7.70 | 341,498.0000 | 0 | 0.10% | 0.00% |
| Jan. 29, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 2005 | $9.64 | 341,846.0000 | 0 | 0.58% | 0.00% |
| Jan. 16, 2024 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Common Stock | 200000 | $0.00 | 343,851.0000 | 0 | 139.03% | 0.00% |
| Dec. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 294 | $11.51 | 143,851.0000 | 0 | 0.20% | 0.00% |
| Oct. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1697 | $6.03 | 144,145.0000 | 0 | 1.16% | 0.00% |
| Sept. 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 294 | $8.38 | 145,842.0000 | 0 | 0.20% | 0.00% |
| July 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 1693 | $11.80 | 146,136.0000 | 0 | 1.15% | 0.00% |
| June 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 294 | $12.12 | 147,829.0000 | 0 | 0.20% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 2012 | $11.16 | 148,123.0000 | 0 | 1.34% | 0.00% |
| April 28, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 863 | $11.16 | 149,272.0000 | 0 | 0.57% | 0.00% |
| March 27, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 347 | $15.36 | 150,135.0000 | 0 | 0.23% | 0.00% |
| Jan. 30, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | S | Common Stock | 864 | $21.56 | 150,482.0000 | 0 | 0.57% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Stock Option (Right to Buy) | 97630 | $0.00 | 97,630.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Stock Option (Right to Buy) | 104600 | $0.00 | 104,600.0000 | 0 | 9999.99% | 0.00% |
| Jan. 17, 2023 | Relay Therapeutics, Inc. | $RLAY | Catinazzo Thomas | Chief Financial Officer | A | Common Stock | 101115 | $0.00 | 151,346.0000 | 0 | 201.30% | 0.00% |